» Articles » PMID: 22518317

A Versatile Polymer Micelle Drug Delivery System for Encapsulation and in Vivo Stabilization of Hydrophobic Anticancer Drugs

Overview
Journal J Drug Deliv
Date 2012 Apr 21
PMID 22518317
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Chemotherapeutic drugs are widely used for the treatment of cancer; however, use of these drugs is often associated with patient toxicity and poor tumor delivery. Micellar drug carriers offer a promising approach for formulating and achieving improved delivery of hydrophobic chemotherapeutic drugs; however, conventional micelles do not have long-term stability in complex biological environments such as plasma. To address this problem, a novel triblock copolymer has been developed to encapsulate several different hydrophobic drugs into stable polymer micelles. These micelles have been engineered to be stable at low concentrations even in complex biological fluids, and to release cargo in response to low pH environments, such as in the tumor microenvironment or in tumor cell endosomes. The particle sizes of drugs encapsulated ranged between 30-80 nm, with no relationship to the hydrophobicity of the drug. Stabilization of the micelles below the critical micelle concentration was demonstrated using a pH-reversible crosslinking mechanism, with proof-of-concept demonstrated in both in vitro and in vivo models. Described herein is polymer micelle drug delivery system that enables encapsulation and stabilization of a wide variety of chemotherapeutic drugs in a single platform.

Citing Articles

Well-Defined pH-Sensitive Self-Assembled Triblock Copolymer-Based Crosslinked Micelles for Efficient Cancer Chemotherapy.

Mohamed M, Singh A, Prasad P, Cheng C Molecules. 2022; 27(23).

PMID: 36500245 PMC: 9735831. DOI: 10.3390/molecules27238153.


Selective Targeting and Eradication of Various Human Non-Small Cell Lung Cancer Cell Lines Using Self-Assembled Aptamer-Decorated Nanoparticles.

Barak D, Engelberg S, Assaraf Y, Livney Y Pharmaceutics. 2022; 14(8).

PMID: 36015276 PMC: 9414336. DOI: 10.3390/pharmaceutics14081650.


Biotinylated Polymer-Ruthenium Conjugates: In Vitro and In Vivo Studies in a Triple-Negative Breast Cancer Model.

Corte-Real L, Bras A, Pilon A, Mendes N, Ribeiro A, Martins T Pharmaceutics. 2022; 14(7).

PMID: 35890283 PMC: 9315599. DOI: 10.3390/pharmaceutics14071388.


A Review of Polymeric Micelles and Their Applications.

Perumal S, Atchudan R, Lee W Polymers (Basel). 2022; 14(12).

PMID: 35746086 PMC: 9230755. DOI: 10.3390/polym14122510.


The Drug-Loaded Electrospun Poly(ε-Caprolactone) Mats for Therapeutic Application.

Siskova A, Buckova M, Kronekova Z, Kleinova A, Nagy S, Rydz J Nanomaterials (Basel). 2021; 11(4).

PMID: 33916638 PMC: 8066245. DOI: 10.3390/nano11040922.


References
1.
Wu X, Kim J, Koo H, Bae S, Shin H, Kim M . Tumor-targeting peptide conjugated pH-responsive micelles as a potential drug carrier for cancer therapy. Bioconjug Chem. 2010; 21(2):208-13. DOI: 10.1021/bc9005283. View

2.
Kim D, Lee E, Oh K, Gao Z, Bae Y . Doxorubicin-loaded polymeric micelle overcomes multidrug resistance of cancer by double-targeting folate receptor and early endosomal pH. Small. 2008; 4(11):2043-50. PMC: 2582593. DOI: 10.1002/smll.200701275. View

3.
Savic R, Azzam T, Eisenberg A, Maysinger D . Assessment of the integrity of poly(caprolactone)-b-poly(ethylene oxide) micelles under biological conditions: a fluorogenic-based approach. Langmuir. 2006; 22(8):3570-8. DOI: 10.1021/la0531998. View

4.
Nasongkla N, Bey E, Ren J, Ai H, Khemtong C, Guthi J . Multifunctional polymeric micelles as cancer-targeted, MRI-ultrasensitive drug delivery systems. Nano Lett. 2006; 6(11):2427-30. DOI: 10.1021/nl061412u. View

5.
Rijcken C, Snel C, Schiffelers R, van Nostrum C, Hennink W . Hydrolysable core-crosslinked thermosensitive polymeric micelles: synthesis, characterisation and in vivo studies. Biomaterials. 2007; 28(36):5581-93. DOI: 10.1016/j.biomaterials.2007.08.047. View